Radiotherapy protocol deviations and clinical outcomes: A meta-analysis of cooperative group clinical trials

Journal of the National Cancer Institute

Volumn 105, Issue 6, 2013, Pages 387-393

  Ohri, Nitin ^a   Shen, Xinglei ^b   Dicker, Adam P ^d   Doyle, Laura A ^d   Harrison, Amy S ^d   Showalter, Timothy N ^c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CONTROLLED CLINICAL TRIAL (TOPIC); EVENT FREE SURVIVAL; EWING SARCOMA; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; MEDULLOBLASTOMA; META ANALYSIS; NEUROECTODERM TUMOR; OUTCOME ASSESSMENT; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT FAILURE;

CLINICAL PROTOCOLS; CLINICAL TRIALS AS TOPIC; DISEASE-FREE SURVIVAL; HUMANS; MULTICENTER STUDIES AS TOPIC; NEOPLASMS; ODDS RATIO; PATIENT COMPLIANCE; PUBLICATION BIAS; QUALITY ASSURANCE, HEALTH CARE; RADIOTHERAPY; SELECTION BIAS; TREATMENT FAILURE;

EID: 84875596379     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djt001     Document Type: Review

References (28)

1. Lomas J. Quality assurance and effectiveness in health care: an overview. Qual Assur Health Care. 1990;2(1):5-12.
2. Williamson JF, Dunscombe PB, Sharpe MB, Thomadsen BR, Purdy JA, Deye JA. Quality assurance needs for modern image-based radiotherapy: recommendations from 2007 interorganizational symposium on "quality assurance of radiation therapy: challenges of advanced technology". Int J Radiat Oncol Biol Phys. 2008;71(1 Suppl):S2-12.
3. Crozier C, Erickson-Wittmann B, Movsas B, Khalid N, Wilson JF. Shifting the focus to practice quality improvement in radiation oncology. J Healthc Qual. 2011;33(5):49-57.
4. Pawlicki T, Dunscombe P, Mundt AJ. Quality Assurance and Safety for Radiotherapy. Taylor & Francis Group; FL: Boca Raton; 2010.
5. Bentzen SM, Bernier J, Davis JB, et al. Clinical impact of dosimetry quality assurance programmes assessed by radiobiological modelling of data from the thermoluminescent dosimetry study of the European Organization for Research and Treatment of Cancer. Eur J Cancer. 2000;36(5):615-620.
6. Ibbott GS, Hanson WF, O'Meara E, et al. Dose specification and quality assurance of radiation therapy oncology group protocol 95-17; a cooperative group study of iridium-192 breast implants as sole therapy. Int J Radiat Oncol Biol Phys. 2007;69(5):1572-1578.
7. Pettersen MN, Aird E, Olsen DR. Quality assurance of dosimetry and the impact on sample size in randomized clinical trials. Radiother Oncol. 2008;86(2):195-199.
8. Bekelman JE, Deye JA, Vikram B, et al. Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials-report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance. Int J Radiat Oncol Biol Phys. 2012;83(3):782-790.
9. Abrams RA, Winter KA, Regine WF, et al. Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704-A phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 2012;82(2):809-816.
10. Peters LJ, O'Sullivan B, Giralt J, et al. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. J Clin Oncol. 2010;28(18):2996-3001.
11. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
12. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17(24):2815-2834.
13. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10(1):101-129.
14. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634.
15. Taylor RE, Bailey CC, Robinson KJ, et al. Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma. Int J Radiat Oncol Biol Phys. 2004;58(4):1184-1193.
16. Taylor RE, Donachie PH, Weston CL, et al. Impact of radiotherapy parameters on outcome for patients with supratentorial primitive neuroectodermal tumours entered into the SIOP/UKCCSG PNET 3 study. Radiother Oncol. 2009;92(1):83-88.
17. Khalil AA, Bentzen SM, Bernier J, et al. Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas. Int J Radiat Oncol Biol Phys. 2003;55(3):568-575.
18. Million L, Anderson J, Breneman J, et al. Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: a report from the Children's Oncology Group. Int J Radiat Oncol Biol Phys. 2011;80(2): 333-338.
19. Eisbruch A, Harris J, Garden AS, et al. Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for earlystage oropharyngeal cancer (RTOG 00-22). Int J Radiat Oncol Biol Phys. 2010;76(5):1333-1338.
20. Perez CA, Stanley K, Grundy G, et al. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung: report by the Radiation Therapy Oncology Group. Cancer. 1982;50(6):1091-1099.
21. White JE, Chen T, McCracken J, et al. The influence of radiation therapy quality control on survival, response and sites of relapse in oat cell carcinoma of the lung: preliminary report of a Southwest Oncology Group study. Cancer. 1982;50(6):1084-1090.
22. Carrie C, Hoffstetter S, Gomez F, et al. Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Pediatric Oncology (SFOP). Int J Radiat Oncol Biol Phys. 1999;45(2):435-439.
23. Miralbell R, Fitzgerald TJ, Laurie F, et al. Radiotherapy in pediatric medulloblastoma: quality assessment of Pediatric Oncology Group Trial 9031. Int J Radiat Oncol Biol Phys. 2006;64(5):1325-1330.
24. Donaldson SS, Torrey M, Link MP, et al. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group. Int J Radiat Oncol Biol Phys. 1998;42(1): 125-135.
25. Picozzi VJ, Pisters PW, Vickers SM, Strasberg SM. Strength of the evidence: adjuvant therapy for resected pancreatic cancer. J Gastrointest Surg. 2008;12(4):657-661.
26. Weber DC, Poortmans PM, Hurkmans CW, Aird E, Gulyban A, Fairchild A. Quality assurance for prospective EORTC radiation oncology trials: the challenges of advanced technology in a multicenter international setting. Radiother Oncol. 2011;100(1):150-156.
27. Krejcarek SC, Grant PE, Henson JW, Tarbell NJ, Yock TI. Physiologic and radiographic evidence of the distal edge of the proton beam in craniospinal irradiation. Int J Radiat Oncol Biol Phys. 2007;68(3): 646-649.
28. Den RB, Nowak K, Buzurovic I, et al. Implanted dosimeters identify radiation overdoses during IMRT for prostate cancer. Int J Radiat Oncol Biol Phys. 2012;83(3):e371-e376.